| 发明名称 |
Use of EPA and DHA in secondary prevention |
| 摘要 |
The invention is directed to a method for preventing cerebral damage in patients having symptoms of atherosclerosis of arteries supplying the brain by administering to the patient a therapeutically effective amount of a composition comprising eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or a combination thereof.
|
| 申请公布号 |
US2005171200(A1) |
申请公布日期 |
2005.08.04 |
| 申请号 |
US20040979751 |
申请日期 |
2004.11.02 |
| 申请人 |
CALDER PHILIP;GRIMBLE ROBERT;GALLAGHER PATRICK;SHEARMAN CLIFF |
发明人 |
CALDER PHILIP;GRIMBLE ROBERT;GALLAGHER PATRICK;SHEARMAN CLIFF |
| 分类号 |
A23L1/30;A61K9/48;A61K31/202;A61K31/22;(IPC1-7):A61K31/202 |
主分类号 |
A23L1/30 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
